All use must remain within research-only boundaries - neither compound is approved by the FDA or EMA, BPC-157 was placed on the FDA 503A Category 2 list in 2023, and TB-500 is on the WADA Prohibited List under class S2
Anecdotal/observational reports (body composition, energy, recovery) exist in performance settings, but lack standardized dosing, controls, and validated endpoints
Best BPC-157 Dosage for Gut Health: Protocol Comparison Key Takeaways BPC-157 dosages for gut healing typically range 250500 mcg daily via subcutaneous injection, with tissue-repair effects observed within 24 weeks at 10 mcg/kg bodyweight
This combined approach showcases the potential for a comprehensive solution in managing inflammation-related ailments
Storage requirements for maximum longevity How you store your GHK-Cu directly impacts how long it remains effective